Discussions tagged “bloodCancer”

Venclexta is a novel medicine gaining attention for its effectiveness in treating certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). This medication works by targeting and blocking a specific protein in cancer cells called BCL-2, which is crucial for the survival of these malignant cells. By inhibiting this protein, Venclexta helps the cancer cells die off, offering a new avenue for cancer treatment. While Venclexta shows promise, it is important to be aware of its possible side effects, both urgent and common. The urgency of the side effects is evident: allergic reactions, electrolyte imbalances, infections, and tumor lysis syndrome are some of the most critical. Understanding these risks and how to manage them can make the treatment safer. This discussion aims to explore Venclexta's benefits, potential side effects, and how people are coping with this new therapy.